YOU SEARCHED BY...

Remove all

SEARCH BY...

Contract Service Directory

Contract Service Directory

AstraCrux





Company Headquarters

3F, No.95, Guangfu North Road
Songshan District
Taipei, 105
Taiwan

Contract Service Directory

    Related Content

    • Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
      Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience

      Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience

      Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
    • Life Science Success Podcast: Matt Hicks

      Life Science Success Podcast: Matt Hicks

      ...
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Asahi Kasei Pharma Contracts ProBioGen

      Asahi Kasei Pharma Contracts ProBioGen

      Will use ProBioGen’s technologies for the advancement of its biologics pipeline.
      Contract Pharma Staff 11.18.20
    • A Potential “Marriage”

      A Potential “Marriage”

      Initiator companies and generics/CMOs working together.
      Emil W. Ciurczak, DoraMaxx Consulting 11.17.20
    • Information Technology | Supply Chain
      The Pandemic & The Pharma Industry: 3 Things to Know

      The Pandemic & The Pharma Industry: 3 Things to Know

      The importance of vendor contract visibility, an increase in intense legal scrutiny, and new technology for greater agility and control.
      Colin Earl, CTO at Agiloft 11.16.20
    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
      Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy

      Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy

      Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.
      10.20.20
    • The Pandemic’s Become an Insurmountable Opportunity

      The Pandemic’s Become an Insurmountable Opportunity

      Every Cloud has a Silver Lining(?)
      Emil W. Ciurczak, Contributing Editor 10.14.20
    • Breaking News | Collaborations & Alliances | CRO News
      BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services

      BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services

      Will support new medical countermeasure research in the fight against emerging infectious disease.
      Contract Pharma Staff 10.08.20
    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Metrics Contract Services Begins $10M Plant Expansion

      Metrics Contract Services Begins $10M Plant Expansion

      Adds 3,760 square feet of production space to the current facility, providing added flexibility and capacity to the CDMO.
      Contract Pharma Staff 09.22.20
    • Breaking News | Facilities | Industry News
      CoreRx Fully Operational in New Product Development Center

      CoreRx Fully Operational in New Product Development Center

      Expansion gives CoreRx’s clients access to over 150,000 sq. ft. of space at the ICOT center campus.
      Contract Pharma Staff 08.10.20
    • APIs | cGMP Manufacture | Clinical Trials | Supply Chain
      Evaluating Pharma Amid COVID-19

      Evaluating Pharma Amid COVID-19

      Dr. Ural of Ernst & Young LLP discusses market dynamics, enduring therapeutic areas, near term M&A, and how industry can use this time for transformation
      Kristin Brooks, Contract Pharma 05.18.20
    • cGMP Manufacture | Clinical Trials | Drug Development | Information Technology | R&D
      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      COVID-19’s Long-Term Impact on Drug Development: The New Pragmatism

      The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.
      Paul Bridges SVP Worldwide Head Regulatory & Access, Parexel and Sheela Hegde, Partner and Managing Director, Health Advances 05.18.20
    • Clinical Trials | CRO News | Drug Development | Information Technology | R&D
      CRO Industry Update

      CRO Industry Update

      Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
      Kristin Brooks, Contract Pharma 04.27.20